Assembly Biosciences, Inc. (ASMB)
35.79
-0.08
(-0.22%)
USD |
NASDAQ |
Dec 11, 16:00
35.79
0.00 (0.00%)
After-Hours: 20:00
Assembly Biosciences Cash from Investing (Quarterly): -158.27M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Arvinas, Inc. | 63.50M |
| Supernus Pharmaceuticals, Inc. | 48.71M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.13M |
| Cash from Financing (Quarterly) | 171.93M |
| Free Cash Flow | -55.78M |
| Free Cash Flow Per Share (Quarterly) | -1.196 |
| Free Cash Flow to Equity (Quarterly) | -15.05M |
| Free Cash Flow to Firm (Quarterly) | -15.18M |
| Free Cash Flow Yield | -18.11% |